Rankings
▼
Calendar
CRIS FY 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$14M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
+31.5% YoY
Gross Profit
$9M
95.0% margin
Operating Income
-$50M
-502.7% margin
Net Income
-$53M
-538.7% margin
EPS (Diluted)
$-35.75
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$49M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$74M
Total Liabilities
$50M
Stockholders' Equity
$24M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$8M
+31.5%
Gross Profit
$9M
$7M
+31.9%
Operating Income
-$50M
-$58M
+14.3%
Net Income
-$53M
-$60M
+11.7%
← Q4 2016
All Quarters
Q1 2017 →